Ubrelvy 100 MG tablet UD 16S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QJ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,998
Award facts
- Contract value 100% obligated
- $47,997.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,997.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-unit dose packaging) with an ultimate completion date of December 15, 2025. This non-competitive, non-set-aside delivery order was issued on December 12, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is an acute migraine treatment indicated for adults experiencing migraine with or without aura, representing a specialty pharmaceutical product within the Defense Health Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive contract portfolio with the Defense Logistics Agency for supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The underlying IDC structure provides flexible access to pharmaceutical products while enabling the contractor to serve military treatment facilities, the Defense Health Agency, and other federal healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F5QJ8?
SPE2DR26F5QJ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F5QJ8 worth?
The government has obligated $47,998 on SPE2DR26F5QJ8.
Is contract SPE2DR26F5QJ8 an order under another contract?
Yes. SPE2DR26F5QJ8 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QJ8 competed?
The extent of competition for SPE2DR26F5QJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award